Clinical Practice and Future Needs in Recombinant Human Granulocyte Colony-stimulating Factor Treatment: a Review of Randomized Trials in Clinical Haemato-oncology

Author： Johnsen HE  

Publisher： Field House Publishing

ISSN： 0300-0605

Source： The Journal of International Medical Research, Vol.29, Iss.2, 2001-03, pp. : 87-99

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Granulocyte Colony-Stimulating Factor (G-CSF) in the Mechanism of Human Ovulation and its Clinical Usefulness

By  

Current Medicinal Chemistry, Vol. 15, Iss. 6, 2008-03 ,pp. : 604-613

Bentham Science Publishers

Access to resources Recommend Favorite

Effects of Recombinant Human Granulocyte Colony-Stimulating Factor (Filgrastim) on ECG Parameters in Neutropenic Patients: A Single-Centre, Prospective Study

By Guneysel Ozlem   >   Denizbasi Arzu  

Clinical Drug Investigation, Vol. 29, Iss. 8, 2009-08 ,pp. : 551-555

Adis International

Access to resources Recommend Favorite

Granulocyte Colony-stimulating Factor as the Expecting Sword for the Treatment of Severe Sepsis

By  

Current Pharmaceutical Design, Vol. 9, Iss. 14, 2003-05 ,pp. : 1115-1120

Bentham Science Publishers

Access to resources Recommend Favorite

Improving the Oral Efficacy of Recombinant Granulocyte Colony-Stimulating Factor and Transferrin Fusion Protein by Spacer Optimization

By Bai Yun   Shen Wei-Chiang  

Pharmaceutical Research, Vol. 23, Iss. 9, 2006-09 ,pp. : 2116-2121

Springer Publishing Company

Access to resources Recommend Favorite

Economic Evaluations of Granulocyte Colony-Stimulating Factor: In the Prevention and Treatment of Chemotherapy-Induced Neutropenia

By Esser M.   Brunner H.  

PharmacoEconomics, Vol. 21, Iss. 18, 2003-01 ,pp. : 1295-1313

Adis International

Access to resources Recommend Favorite